Cargando…

Outcome measures assisting treatment optimization in multiple sclerosis

OBJECTIVE: To review instruments used to assess disease stability or progression in persons with multiple sclerosis (pwMS) that can guide clinicians in optimizing therapy. METHODS: A non-systematic review of scientific literature was undertaken to explore modalities of monitoring symptoms and the di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pardo, Gabriel, Coates, Samantha, Okuda, Darin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857110/ https://www.ncbi.nlm.nih.gov/pubmed/34338857 http://dx.doi.org/10.1007/s00415-021-10674-8

Ejemplares similares

Optimizing treatment success in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options
por: Krajnc, Nik, et al.
Publicado: (2021)

The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No
por: Tremlett, Helen, et al.
Publicado: (2021)

Outcome Measures in Clinical Trials for Multiple Sclerosis
por: van Munster, Caspar E. P., et al.
Publicado: (2017)

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence
por: Patti, Francesco
Publicado: (2010)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
por: Pardo, Gabriel, et al.
Publicado: (2017)

Vision and vision-related outcome measures in multiple sclerosis
por: Balcer, Laura J., et al.
Publicado: (2015)

The Multiple Sclerosis Treatment Optimization Program
por: Langer‐Gould, Annette, et al.
Publicado: (2021)

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trial
por: Okuda, Darin T, et al.
Publicado: (2022)

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study
por: Okuda, Darin T, et al.
Publicado: (2023)

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
por: Sá, María José, et al.
Publicado: (2020)

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
por: Uitdehaag, Bernard M. J.
Publicado: (2018)

Glatiramer in the treatment of multiple sclerosis
por: Rizvi, Syed A, et al.
Publicado: (2006)

Natalizumab in the treatment of multiple sclerosis
por: Brown, Brandon A
Publicado: (2009)

Alemtuzumab in the treatment of multiple sclerosis
por: Fernandez, Óscar
Publicado: (2014)

Alemtuzumab for the treatment of multiple sclerosis
por: Willis, Mark D, et al.
Publicado: (2015)

Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?
por: Nathoo, Nabeela, et al.
Publicado: (2023)

Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study
por: FJELDSTAD-PARDO, CECILIE, et al.
Publicado: (2018)

Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review
por: Alexander, Sarah, et al.
Publicado: (2020)

Optimal management of multiple sclerosis during pregnancy: current perspectives
por: Borisow, Nadja, et al.
Publicado: (2014)

Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Imaging outcome measures for progressive multiple sclerosis trials
por: Moccia, Marcello, et al.
Publicado: (2017)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis
por: Brenton, J. Nicholas, et al.
Publicado: (2019)

Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
por: Motl, Robert W, et al.
Publicado: (2017)

Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
por: Wens, Inez, et al.
Publicado: (2021)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Emerging therapies for treatment of multiple sclerosis
por: Corboy, John R, et al.
Publicado: (2010)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Recent advances in the treatment of multiple sclerosis
por: Bennett, Jeffrey L, et al.
Publicado: (2010)

The Danish Multiple Sclerosis Treatment Register
por: Magyari, Melinda, et al.
Publicado: (2016)

Multiple sclerosis: Pathology, diagnosis and treatments
por: Huang, Wen-Juan, et al.
Publicado: (2017)

Multiple Sclerosis: Immunopathology and Treatment Update
por: Dargahi, Narges, et al.
Publicado: (2017)

An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis
por: Kenyon, Katherine Hope, et al.
Publicado: (2022)

Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2023)

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
por: Ozel, Osman, et al.
Publicado: (2019)

Obesity and Multiple Sclerosis—A Multifaceted Association
por: Schreiner, Thomas-Gabriel, et al.
Publicado: (2021)

Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
por: Lavery, Amy M., et al.
Publicado: (2014)

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vv1rbc2aj62rlrketbsphmhocg